{"id":15629,"date":"2021-09-16T14:08:52","date_gmt":"2021-09-16T12:08:52","guid":{"rendered":"https:\/\/www.fbm.nl\/sale-of-bioconnect-group-to-addlife\/"},"modified":"2024-11-14T18:03:50","modified_gmt":"2024-11-14T17:03:50","slug":"sale-of-bioconnect-group-to-addlife","status":"publish","type":"post","link":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/","title":{"rendered":"Sale of BioConnect Group to AddLife"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"15629\" class=\"elementor elementor-15629 elementor-11383\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5c1ce5e e-flex e-con-boxed e-con e-parent\" data-id=\"5c1ce5e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a94bba0 elementor-widget elementor-widget-heading\" data-id=\"a94bba0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">\nFBM assisted Bio-Connect Group shareholders in the sale of the company to AddLife.<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1bbd95f elementor-widget elementor-widget-text-editor\" data-id=\"1bbd95f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p dir=\"ltr\" data-placeholder=\"Vertaling\"><span class=\"Y2IQFc\" lang=\"nl\"><strong><a href=\"https:\/\/www.bio-connect.nl\/\">Bio-Connect Group<\/a><\/strong> (&#8220;BioConnect&#8221;) is a distributor within the Healthcare sector with operations in the Benelux countries and locations in the Netherlands and Belgium. <\/span>BioConnect has a large portfolio of products for medical screening and diagnostics and sells these mainly to research companies within the sectors  <span class=\"Y2IQFc\" lang=\"nl\">Diagnostics, Food, Pharma and Veterinary. Bio-Connect customers are primarily universities and hospital laboratories, as well as private and government-funded research organizations.   <\/span><\/p>\n<p dir=\"ltr\" data-placeholder=\"Vertaling\"><span class=\"Y2IQFc\" lang=\"nl\"><strong><a href=\"https:\/\/www.add.life\/en\/\">AddLife  <\/a><\/strong><\/span><span class=\"Y2IQFc\" lang=\"nl\">  is a listed Swedish Medtech company operating in the European market. AddLife owns and acquires market leading companies in niche segments with offerings primarily focused on the healthcare sector from research to medical care. AddLife shares have been listed since 2016 on <strong><a href=\"https:\/\/markets.ft.com\/data\/equities\/tearsheet\/profile?s=ALIF%20B:STO\">Nasdaq Stockholm<\/a><\/strong>, Mid Cap. It is headquartered in Stockholm.   <\/span><\/p>\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large XcVN5d tw-ta\" dir=\"ltr\" data-placeholder=\"Vertaling\"><span class=\"Y2IQFc\" lang=\"nl\">The acquisition of <strong><a href=\"https:\/\/www.bio-connect.nl\/\">BioConnect<\/a><\/strong> by <strong><a href=\"https:\/\/www.add.life\/en\/\">AddLife<\/a><\/strong> strengthens AddLife&#8217;s presence in the Benelux and provides opportunities for cooperation with other companies in their portfolio in Europe that are active in the same product segment.  <\/span><span class=\"Y2IQFc\" lang=\"nl\">The Benelux countries are an attractive Life Science market in Europe, where AddLife has been active in Medtech for many years. AddLife continues its expansion in Europe through the acquisition of BioConnect.   <\/span><\/p>\n<p dir=\"ltr\" data-placeholder=\"Vertaling\">FBM acted as counsel to seller.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>FBM assisted Bio-Connect Group shareholders in the sale of the company to AddLife. Bio-Connect Group (&#8220;BioConnect&#8221;) is a distributor within the Healthcare sector with operations in the Benelux countries and locations in the Netherlands and Belgium. BioConnect has a large portfolio of products for medical screening and diagnostics and sells these mainly to research companies [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":15439,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[88],"tags":[89,90],"class_list":["post-15629","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-customer-stories","tag-sell-business","tag-wholesale"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sale of BioConnect Group to AddLife<\/title>\n<meta name=\"description\" content=\"FBM assisted the shareholders of Bio-Connect Group in the sale of the company to AddLife. AddLife is a listed Swedish Medtech company operating in the European market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sale of BioConnect Group to AddLife\" \/>\n<meta property=\"og:description\" content=\"FBM assisted the shareholders of Bio-Connect Group in the sale of the company to AddLife. AddLife is a listed Swedish Medtech company operating in the European market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/\" \/>\n<meta property=\"og:site_name\" content=\"FBM Corporate Finance\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-16T12:08:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-14T17:03:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fbm.nl\/wp-content\/uploads\/2021\/09\/Tumbstone-BioConnect.png?wsr\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Bob Oord\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bob Oord\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/\"},\"author\":{\"name\":\"Bob Oord\",\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/#\\\/schema\\\/person\\\/e4f855129b13737d8d2b035666dcad03\"},\"headline\":\"Sale of BioConnect Group to AddLife\",\"datePublished\":\"2021-09-16T12:08:52+00:00\",\"dateModified\":\"2024-11-14T17:03:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/\"},\"wordCount\":208,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.fbm.nl\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Tumbstone-BioConnect.png?wsr\",\"keywords\":[\"sell business\",\"wholesale\"],\"articleSection\":[\"Customer Stories\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/\",\"url\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/\",\"name\":\"Sale of BioConnect Group to AddLife\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.fbm.nl\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Tumbstone-BioConnect.png?wsr\",\"datePublished\":\"2021-09-16T12:08:52+00:00\",\"dateModified\":\"2024-11-14T17:03:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/#\\\/schema\\\/person\\\/e4f855129b13737d8d2b035666dcad03\"},\"description\":\"FBM assisted the shareholders of Bio-Connect Group in the sale of the company to AddLife. AddLife is a listed Swedish Medtech company operating in the European market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.fbm.nl\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Tumbstone-BioConnect.png?wsr\",\"contentUrl\":\"https:\\\/\\\/www.fbm.nl\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Tumbstone-BioConnect.png?wsr\",\"width\":350,\"height\":280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/sale-of-bioconnect-group-to-addlife\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sale of BioConnect Group to AddLife\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/\",\"name\":\"FBM Corporate Finance\",\"description\":\"Corporate fincance adviseurs met karakter\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/#\\\/schema\\\/person\\\/e4f855129b13737d8d2b035666dcad03\",\"name\":\"Bob Oord\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a79ba9b945417576ea6df7ca1203295da757d9ffda1b9a9cd270308182f8fc30?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a79ba9b945417576ea6df7ca1203295da757d9ffda1b9a9cd270308182f8fc30?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a79ba9b945417576ea6df7ca1203295da757d9ffda1b9a9cd270308182f8fc30?s=96&d=mm&r=g\",\"caption\":\"Bob Oord\"},\"url\":\"https:\\\/\\\/www.fbm.nl\\\/en\\\/author\\\/bobfbm\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sale of BioConnect Group to AddLife","description":"FBM assisted the shareholders of Bio-Connect Group in the sale of the company to AddLife. AddLife is a listed Swedish Medtech company operating in the European market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/","og_locale":"en_US","og_type":"article","og_title":"Sale of BioConnect Group to AddLife","og_description":"FBM assisted the shareholders of Bio-Connect Group in the sale of the company to AddLife. AddLife is a listed Swedish Medtech company operating in the European market.","og_url":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/","og_site_name":"FBM Corporate Finance","article_published_time":"2021-09-16T12:08:52+00:00","article_modified_time":"2024-11-14T17:03:50+00:00","og_image":[{"width":350,"height":280,"url":"https:\/\/www.fbm.nl\/wp-content\/uploads\/2021\/09\/Tumbstone-BioConnect.png?wsr","type":"image\/png"}],"author":"Bob Oord","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Bob Oord","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/#article","isPartOf":{"@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/"},"author":{"name":"Bob Oord","@id":"https:\/\/www.fbm.nl\/en\/#\/schema\/person\/e4f855129b13737d8d2b035666dcad03"},"headline":"Sale of BioConnect Group to AddLife","datePublished":"2021-09-16T12:08:52+00:00","dateModified":"2024-11-14T17:03:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/"},"wordCount":208,"commentCount":0,"image":{"@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fbm.nl\/wp-content\/uploads\/2021\/09\/Tumbstone-BioConnect.png?wsr","keywords":["sell business","wholesale"],"articleSection":["Customer Stories"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/","url":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/","name":"Sale of BioConnect Group to AddLife","isPartOf":{"@id":"https:\/\/www.fbm.nl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/#primaryimage"},"image":{"@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fbm.nl\/wp-content\/uploads\/2021\/09\/Tumbstone-BioConnect.png?wsr","datePublished":"2021-09-16T12:08:52+00:00","dateModified":"2024-11-14T17:03:50+00:00","author":{"@id":"https:\/\/www.fbm.nl\/en\/#\/schema\/person\/e4f855129b13737d8d2b035666dcad03"},"description":"FBM assisted the shareholders of Bio-Connect Group in the sale of the company to AddLife. AddLife is a listed Swedish Medtech company operating in the European market.","breadcrumb":{"@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/#primaryimage","url":"https:\/\/www.fbm.nl\/wp-content\/uploads\/2021\/09\/Tumbstone-BioConnect.png?wsr","contentUrl":"https:\/\/www.fbm.nl\/wp-content\/uploads\/2021\/09\/Tumbstone-BioConnect.png?wsr","width":350,"height":280},{"@type":"BreadcrumbList","@id":"https:\/\/www.fbm.nl\/en\/sale-of-bioconnect-group-to-addlife\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fbm.nl\/en\/homepage\/"},{"@type":"ListItem","position":2,"name":"Sale of BioConnect Group to AddLife"}]},{"@type":"WebSite","@id":"https:\/\/www.fbm.nl\/en\/#website","url":"https:\/\/www.fbm.nl\/en\/","name":"FBM Corporate Finance","description":"Corporate fincance adviseurs met karakter","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fbm.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.fbm.nl\/en\/#\/schema\/person\/e4f855129b13737d8d2b035666dcad03","name":"Bob Oord","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a79ba9b945417576ea6df7ca1203295da757d9ffda1b9a9cd270308182f8fc30?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a79ba9b945417576ea6df7ca1203295da757d9ffda1b9a9cd270308182f8fc30?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a79ba9b945417576ea6df7ca1203295da757d9ffda1b9a9cd270308182f8fc30?s=96&d=mm&r=g","caption":"Bob Oord"},"url":"https:\/\/www.fbm.nl\/en\/author\/bobfbm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/posts\/15629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/comments?post=15629"}],"version-history":[{"count":1,"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/posts\/15629\/revisions"}],"predecessor-version":[{"id":15631,"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/posts\/15629\/revisions\/15631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/media\/15439"}],"wp:attachment":[{"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/media?parent=15629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/categories?post=15629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fbm.nl\/en\/wp-json\/wp\/v2\/tags?post=15629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}